Earnings & Results
Auna posts $384.7 million Q3 revenue as net income falls 57.4% to $5.9 million
By News Desk ·
Key takeaways
- Auna reported third-quarter 2026 revenue of $384.7 million, up 19.4% from a year earlier.
- Net income attributable to common shareholders fell 57.4% to $5.9 million, with diluted earnings per share of $0.08.
- Operating cash flow rose 38.9% to $77.6 million and cash and cash equivalents more than doubled to $178.2 million.
Auna S.A. reported third-quarter 2026 revenue of $384.7 million, up 19.4% from a year earlier, while net income attributable to common shareholders fell 57.4% to $5.9 million. Quiver Quantitative reported the results on November 17, 2026.
Inside Auna's Third-Quarter Results
Auna is a Latin American integrated healthcare platform operating 31 hospitals and clinics across Mexico, Peru, and Colombia, serving 1.4 million health plan members through hospital services and health insurance underwriting under the Auna, Oncosalud, and Clínica Delgado brands.
Gross profit rose to $129.5 million, and operating profit came in at $45.9 million. Diluted earnings per share were $0.08. Cost of sales increased to $255.2 million, reflecting the higher revenue base.
Cash generation was a bright spot, with operating cash flow climbing 38.9% to $77.6 million. Cash and cash equivalents more than doubled to $178.2 million, while purchases of property, plant and equipment totaled $9.5 million. Total liabilities stood at $1.69 billion at quarter-end.
Auna's Revenue Growth and Cost Pressure
Auna reported 3Q26 revenue of S/1,325 million, up 10% FX-neutral, and adjusted EBITDA of S/231 million, down 4.6% FX-neutral, according to FinancialContent Business Page. Mexico's segment EBITDA grew 5% year-over-year, while Colombia's fell 30% due to adverse medical costs and regulatory caps.
Auna's Expansion Moves Before the Quarter
According to akta.pro company records, Auna finalized an addendum with EsSalud in February 2026 to commence construction of Torre Trecca, a 23-story, roughly 59,000 square meter outpatient facility in Lima under a 20-year concession renewable for 18 years, projected to expand EsSalud capacity by about 20% and serve more than 3 million patients annually from mid-2028. In January 2026, Auna formed a strategic partnership with Japan's Sojitz Corporation backed by approximately $500 million to accelerate healthcare expansion across Mexico. In March 2026, Auna launched Johnson & Johnson's VARIPULSE pulsed field ablation technology at Clínica Delgado in Lima.
What Comes Next for Auna
Auna held its analyst and investor day on October 22, 2026, in Lima, where it outlined its integrated healthcare platform strategy across Latin America, according to Seeking Alpha. The Torre Trecca facility is projected to serve patients from mid-2028.